INSYS Therapeutics Inc. (INSY)

4.96
0.18 3.77
NASDAQ : Health Technology
Prev Close 4.78
Open 4.89
Day Low/High 4.73 / 4.97
52 Wk Low/High 3.35 / 11.65
Volume 1.08M
Avg Volume 739.00K
Exchange NASDAQ
Shares Outstanding 74.27M
Market Cap 350.55M
EPS -3.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

FDA Approval Puts GW Pharma, Three Other Cannabis-Related Names in the Spotlight

FDA Approval Puts GW Pharma, Three Other Cannabis-Related Names in the Spotlight

The milestone approval of Epidiolex bodes well for cannabis-based drug stocks GW Pharma, Nemus, Zynerba and Insys.

Seven U.S. Stocks Offering Cannabis Exposure

Seven U.S. Stocks Offering Cannabis Exposure

While cannabis remains illegal on a federal level, these seven names are making early inroads into the growing industry.

Abeona Shares Higher After Pricing Stock Offering -- Biotech Movers

Abeona Shares Higher After Pricing Stock Offering -- Biotech Movers

The clinical-stage biopharmaceutical firm said Oct. 16 it has priced an underwritten public offering of five million shares at $16 apiece.

Three Pot Stocks to Watch for 2017

Three Pot Stocks to Watch for 2017

Donald Trump was not the only big winner on Election Day. The cannabis industry got a spark as well.

Stocks With Earnings Revised Up

This trend is a good indication that business is going well.

Organic IPOs: BioAmber, Insys

Organic IPOs: BioAmber, Insys

From green technology to medicinal marijuana, investors will be surprised at which IPO looks good. Francis Gaskins gives details.